vs
Side-by-side financial comparison of Sphere 3D Corp. (ANY) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
Sphere 3D Corp. is the larger business by last-quarter revenue ($2.7M vs $1.4M, roughly 2.0× PLUS THERAPEUTICS, INC.). On growth, Sphere 3D Corp. posted the faster year-over-year revenue change (3.1% vs -3.2%). PLUS THERAPEUTICS, INC. produced more free cash flow last quarter ($-6.3M vs $-23.6M). Over the past eight quarters, PLUS THERAPEUTICS, INC.'s revenue compounded faster (-9.7% CAGR vs -37.4%).
Sphere 3D Corp is a global technology company specializing in cloud computing, data management, and virtualization solutions. It delivers enterprise-grade products and services tailored for small to medium-sized businesses, large enterprise clients, and public sector entities, focusing on optimizing IT infrastructure efficiency and cutting operational costs for end users.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
ANY vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $1.4M |
| Net Profit | — | $-5.7M |
| Gross Margin | — | — |
| Operating Margin | -372.7% | -420.0% |
| Net Margin | — | -417.9% |
| Revenue YoY | 3.1% | -3.2% |
| Net Profit YoY | — | -46.4% |
| EPS (diluted) | $-6.96 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $1.4M | ||
| Q3 25 | $2.6M | $1.4M | ||
| Q2 25 | $3.0M | $1.4M | ||
| Q1 25 | $2.8M | $1.1M | ||
| Q4 24 | $2.6M | $1.4M | ||
| Q3 24 | $2.4M | $1.5M | ||
| Q2 24 | $4.7M | $1.3M | ||
| Q1 24 | $6.9M | $1.7M |
| Q4 25 | — | $-5.7M | ||
| Q3 25 | $-4.2M | $-4.4M | ||
| Q2 25 | $1.7M | $5.2M | ||
| Q1 25 | $-8.8M | $-17.4M | ||
| Q4 24 | — | $-3.9M | ||
| Q3 24 | $104.0K | $-2.9M | ||
| Q2 24 | $2.1M | $-2.9M | ||
| Q1 24 | $-4.5M | $-3.3M |
| Q4 25 | — | — | ||
| Q3 25 | 25.4% | — | ||
| Q2 25 | 23.8% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -16.0% | — | ||
| Q2 24 | 15.2% | — | ||
| Q1 24 | 38.0% | — |
| Q4 25 | -372.7% | -420.0% | ||
| Q3 25 | -153.8% | -320.8% | ||
| Q2 25 | -87.0% | -110.6% | ||
| Q1 25 | -184.2% | -333.9% | ||
| Q4 24 | -328.7% | -276.2% | ||
| Q3 24 | -218.8% | -260.9% | ||
| Q2 24 | -122.4% | -289.1% | ||
| Q1 24 | -26.9% | -196.7% |
| Q4 25 | — | -417.9% | ||
| Q3 25 | -162.0% | -316.6% | ||
| Q2 25 | 55.2% | 370.6% | ||
| Q1 25 | -311.9% | -1643.2% | ||
| Q4 24 | — | -276.4% | ||
| Q3 24 | 4.4% | -197.4% | ||
| Q2 24 | 45.5% | -229.9% | ||
| Q1 24 | -64.5% | -194.5% |
| Q4 25 | $-6.96 | $0.95 | ||
| Q3 25 | $-0.15 | $-0.04 | ||
| Q2 25 | $0.06 | $-0.01 | ||
| Q1 25 | $-0.32 | $-1.19 | ||
| Q4 24 | $-4.62 | $-0.51 | ||
| Q3 24 | $0.01 | $-0.37 | ||
| Q2 24 | $0.10 | $-0.71 | ||
| Q1 24 | $-0.27 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.7M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.3M | $4.0M |
| Total Assets | $25.1M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.7M | $8.6M | ||
| Q3 25 | $5.3M | $16.6M | ||
| Q2 25 | $4.7M | $6.9M | ||
| Q1 25 | $2.8M | $9.9M | ||
| Q4 24 | $5.4M | $3.6M | ||
| Q3 24 | $5.0M | $4.8M | ||
| Q2 24 | $4.3M | $8.4M | ||
| Q1 24 | $9.3M | $3.2M |
| Q4 25 | $23.3M | $4.0M | ||
| Q3 25 | $29.5M | $5.1M | ||
| Q2 25 | $32.7M | $3.0M | ||
| Q1 25 | $30.7M | $-23.6M | ||
| Q4 24 | $39.3M | $-8.9M | ||
| Q3 24 | $35.8M | $-5.2M | ||
| Q2 24 | $33.4M | $-7.6M | ||
| Q1 24 | $27.5M | $-4.8M |
| Q4 25 | $25.1M | $16.3M | ||
| Q3 25 | $31.1M | $18.7M | ||
| Q2 25 | $34.4M | $10.3M | ||
| Q1 25 | $34.3M | $12.1M | ||
| Q4 24 | $43.2M | $6.6M | ||
| Q3 24 | $44.3M | $7.0M | ||
| Q2 24 | $44.0M | $11.2M | ||
| Q1 24 | $42.0M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | $-6.3M |
| Free Cash FlowOCF − Capex | $-23.6M | $-6.3M |
| FCF MarginFCF / Revenue | -867.3% | -459.9% |
| Capex IntensityCapex / Revenue | 275.4% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-40.5M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.1M | $-6.3M | ||
| Q3 25 | $-3.5M | $-2.5M | ||
| Q2 25 | $-5.8M | $-5.8M | ||
| Q1 25 | $-4.1M | $-6.2M | ||
| Q4 24 | $-4.6M | $-1.2M | ||
| Q3 24 | $290.0K | $-3.7M | ||
| Q2 24 | $-3.3M | $-1.1M | ||
| Q1 24 | $-58.0K | $-4.5M |
| Q4 25 | $-23.6M | $-6.3M | ||
| Q3 25 | $-5.7M | $-2.6M | ||
| Q2 25 | $-6.0M | $-5.8M | ||
| Q1 25 | $-5.1M | $-6.2M | ||
| Q4 24 | $-13.5M | $-1.2M | ||
| Q3 24 | $-4.3M | $-3.7M | ||
| Q2 24 | — | $-1.2M | ||
| Q1 24 | — | $-4.6M |
| Q4 25 | -867.3% | -459.9% | ||
| Q3 25 | -218.7% | -184.3% | ||
| Q2 25 | -200.5% | -417.6% | ||
| Q1 25 | -181.2% | -583.1% | ||
| Q4 24 | -511.9% | -86.5% | ||
| Q3 24 | -184.4% | -253.7% | ||
| Q2 24 | — | -96.2% | ||
| Q1 24 | — | -271.5% |
| Q4 25 | 275.4% | 2.2% | ||
| Q3 25 | 86.5% | 1.9% | ||
| Q2 25 | 6.6% | 0.5% | ||
| Q1 25 | 36.4% | 0.3% | ||
| Q4 24 | 338.7% | 0.8% | ||
| Q3 24 | 196.7% | 1.0% | ||
| Q2 24 | 0.0% | 6.3% | ||
| Q1 24 | 0.0% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -3.51× | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.79× | — | ||
| Q2 24 | -1.55× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
